According to population-based invasive pneumococcal surveillance in the United States during 2007, 898 (26%) of 3,511 isolates were penicillin nonsusceptible. Non-7-valent pneumococcal conjugate vaccine (PCV7) serotypes other than 19A accounted for 40% of these penicillin-nonsusceptible isolates; of these, serotypes 15A (11%), 23A (8%), 35B (8%), and 6C (5%) were most common (cumulatively 32% of penicillin-nonsusceptible isolates). Each except 6C represented a single serotype and clonal complex combination that predated the introduction of PCV7. We evaluated the genetic characteristics and nonsusceptibility to penicillin of non-PCV7 serotypes, and we found increased proportions of specific penicillin-nonsusceptible clones in serotypes 15A, 23A, 35B, and 6C, which potentially indicates a basic change of population structure within these individual serotypes.
Implementation of the 7-valent pneumococcal conjugate vaccine (PCV7) in 2000 led to a dramatic decrease in invasive pneumococcal disease (IPD) in the vaccinated population, and a pronounced herd effect further decreased cases in unvaccinated children and older individuals [1, 2] . Prior to PCV7 introduction, most antibiotic resistance was found within 5 of the 7 PCV7 serotypes, together with the vaccine-related serotype 6A. Thus, the decrease in the incidence of IPD that is caused by vaccine serotypes had the concomitant effect of a decrease in the incidence of IPD that is caused by resistant pneumococci [3] .
During recent years, increases in cases of IPD caused by nonvaccine serotypes have been observed in the United States [4] . The primary contributor to this increase has been serotype 19A, in which the proportion of antibiotic-resistant isolates has greatly increased [5, 6] . We have found that the majority of penicillin-resistant 19A isolates are associated with clonal complexes that had initially been associated with PCV7 serotypes [5] [6] [7] . Many of these associations had been observed prior to the introduction of PCV7, indicating that serotype-switching events have long played a key role in the current population genetic structure of penicillinresistant, invasive 19A strains. We sought to evaluate the genetic characteristics and nonsusceptibility to penicillin associated with non-PCV7 serotypes (other than type 19A) that are common causes of IPD in the post-PCV7 era [4] .
MATERIALS AND METHODS
Cases of IPD were defined by the isolation of pneumococci from a normally sterile site (eg, blood, cere- brospinal fluid, or pleural fluid) in residents of the surveillance population of the Active Bacterial Core surveillance (ABCs) of the Centers for Disease Control and Prevention (CDC) [6] . The surveillance population during 2005 was 27.8 million and ranged from 18.5 million (1999) to nearly 28.6 million (2007). Expansions of the surveillance areas that occurred in 2000, 2002, and 2004 are described at the CDC Web site (http:// www.cdc.gov/abcs/survreports.htm).
Isolates were serotyped by latex agglutination and confirmed by Quellung reaction. Minimal inhibitory concentrations (MICs) for 18 antibiotics were determined by the microdilution method and 2007 interpretive guidelines of the Clinical and Laboratory Standards Institute (CLSI) [8] . In these guidelines, intermediate penicillin resistance is defined by MICs of 0.12-1.0 mg/mL, and penicillin resistance is defined by MICs of у2.0 mg/mL. For the purpose of biologic surveillance, we prefer these more conservative guidelines, compared with subsequent CLSI penicillin breakpoints, at which penicillin sensitivity encompasses values of р2 mg/mL for nonmeningitis infections. Intermediate resistance to b-lactam antibiotics potentially confers a selective advantage for increased carriage of such strains and a subsequent increased association with invasive disease.
The Fisher exact test was used to compare the proportions of penicillin-susceptible and penicillin-nonsusceptible (PNS) IPD isolates within individual serotypes recovered in 2007 with the proportions in 1999. Results for which (2-sided test) P ! .05 were considered statistically significant.
Multilocus sequence typing (MLST) on the selected isolates from 2005 was performed as described elsewhere [9] , with modifications described elsewhere [6] and with different primers posted at the CDC Web site (http://www.cdc.gov/ ncidod/biotech/strep/protocols.htm). Partial allelic data (3-6 alleles), rather than full 7-allele MLST profiles, were determined from the majority of isolates and always included the most variable targets, xpt and ddl. When unusual allelic associations were found, the serotype was verified using polymerase chain reaction (PCR) as described elsewhere [6] , with the same chromosomal template as that used for MLST. When unique partial allelic profiles were encountered for 4 isolates, complete 7-allele profiles were determined and deposited at the Multi Locus Sequence Typing Web site (http://www.mlst.net). On the basis of the results of MLST performed during 1999-2003, we determined that penicillin nonsusceptibility that was associated with serotypes 15A, 23A, and 35B was associated with multilocus sequence types 63, 451, and 338 (ST63, ST451, and ST338, respectively) [10] [11] [12] [13] , each consisting of 7 allelic identifiers reflective of exact 405-483 base sequences. We have found that partial MLST profiles containing the most variable markers (xpt and ddl) and consisting of 3-6 alleles generally suffice to identify sets of highly related sequence types (Bernard W. Beall, unpublished data, 2009). We have observed that these partial MLST data serve as a suitable screen for known clonal complexes that we have associated with these serotypes in this surveillance population over the past decade, and they also serve to reveal serotype switches involving genotypes commonly associated with PCV7-serotype strains. We have found that our own genotypic surveillance experience associating known serotypes and resistance phenotypes with 7-allele MLST profiles, combined with the recorded global pneumococcal MLST database at the Multi Locus Sequence Typing Web site, allowed us to decrease the number of alleles examined while still dividing the surveillance isolates into complexes composed of closely related genotypes. There were 4,009 sequence types in the global pneumococcal database on 26 January 2009, and the number of individual alleles ranged from 134 (aroE) to 328 (ddl) [13] . The putative sequence types found during this study were derived from partial MLST data by screening the global database with the partial profiles to find complete sequence types associated with the same respective serotypes.
RESULTS AND DISCUSSION
Among 3,511 IPD isolates recovered during 2007 through ABCs, 2,619 (75%) were non-PCV7 serotypes other than 19A. In 2007, non-PCV7 serotypes (excluding type 19A) accounted for 56% and 77% of IPD cases among children !5 years old and persons у5 years old, respectively, compared with 15% and 41% in 1999, respectively. Serotype 19A accounted for 53% of PNS isolates in 2007, and other non-PCV7 serotypes accounted for an additional 40% of PNS isolates ( Figure 1 ). The non-PCV7 serotypes (excluding type 19A) that caused the most PNS-related IPD in 2007 were types 15A (11%), 23A (8%), 35B (8%), and 6C (5%). The proportion of PNS isolates recovered within serotypes 15A, 23A, 35B, and 6C increased in post-PCV7 years relative to the proportion in 1999 ( ). P p .002
To determine whether alterations within the basic clonal compositions of PN isolates within these serotypes has occurred during the post-PCV7 era, we determined the antibiotic susceptibility of and partial or complete MLST profiles from all available PNS isolates. The putative sequence types ( Table 2) that were derived from partial MLST data were obtained by screening the global database with the partial profiles to find complete sequence types associated with the same respective serotypes. New allelic combinations were encountered within serotypes 23A, 6C, 16F, and 15B/C ( Table 2 ) that were initially detected by virtue of having unique xpt and ddl profiles within their respective serotypes. The majority of PNS isolates within Table 1 lists numbers of penicillin-nonsusceptible isolates within serotypes 15A, 35B, 23A, and 6C. The most frequently encountered serotypes that accounted for "others" ( ) were 23B (9 isolates) and 15B (8 isolates). Serotypes 9A, 11A, 16F, and 29 each accounted n p 32 for 2 isolates. Serotypes 7F, 10A, 12F, 24A, 33F, 34, and 38 each accounted for 1 isolate.
these serotypes were macrolide resistant; 111 (54%) of the 205 PNS isolates subjected to MLST were erythromycin resistant, and 65 of these were also clindamycin resistant ( Table 2 ).
The data in Table 2 indicate that the 3 predominant serotypes of this class (representing PNS isolates of non-PCV7 serotypes other than 19A and 6A) recovered during 2005, 15A, 35B, and 23A, were each composed of a single set of related genotypes that were similar or identical to those observed within the respective serotypes in the pre-PCV7 period [10, 11] and did not reflect recent serotype-switching events involving PCV7-type recipient strains.
ST63 is composed of the allelic profile aroE-2, gdh-5, gki-36, recP-12, spi-17, xpt-21, and ddl-14. As shown in Table 2 , the complete 7-allele profile and the 2 partial allelic profiles for serotype-15A PNS isolates recovered during 2005 were completely consistent with ST63, which we have associated with type-15A PNS ABCs isolates recovered since 1999 [10, 11] . All 55 isolates tested were resistant to clindamycin and erythromycin, indicating the stability of this phenotype within this clone.
All 3-4-allele profiles for PNS serotype-35B isolates recovered during 2005 were entirely consistent with ST558 (Table 1) , a single-locus variant (SLV) of ST451 that was observed within invasive PNS isolates of this serotype during 1995-2001 [10] . The type-35B PNS isolates displayed a higher degree of blactam antibiotic resistance than did PNS isolates of other non-PCV7 serotypes, reflected by a penicillin MIC range of 1-4 mg/ mL (Table 2) , with 36 of the 54 isolates exhibiting penicillin MICs of 2-4 mg/mL (data not shown).
Serotype-23A PNS isolates recovered during 2005 had 4-7-allele profiles that corresponded to a set of 3 closely related multilocus sequence types. ST338 is the identifier of the serotype-23F clone Colombia 23F -26, and along with the SLV ST172, it was commonly found within PNS serotype-23A IPD isolates recovered in the United States before and after PCV7 introduction [11] [12] [13] . In addition, a new SLV of ST338 (ST4099) was observed. In contrast to the incidence of IPD caused by PCV7 serotype 23F, which has decreased dramatically since PCV7 implementation [1] [2] [3] , the incidence of IPD caused by 23A was observed to have a small but measurable increase.
Serotype 6C was very diverse and was composed of 6 highly related isolate sets including or highly related to ST376, ST473, ST1292 and ST1379 (ST1292 and ST1379 are SLVs previously described within 6C [14] ), ST1390, ST490, and ST1150. Interestingly, we have found that ST376, ST473, and ST1292 are found to represent both serotypes 6A and 6C [14] , suggesting that some of the increase in IPD due to serotype 6C and its increased resistance has been due to independent gene replacement events within capsular biosynthetic loci of different penicillin-nonsusceptible type-6A recipient clones. The net effect in each of these gene replacement events has been replacement of wciN 6A with wciN 6C to effect conversion to the 6C serotype. It is of note that penicillin MICs as high as 2.0 mg/mL were found within ST376 and ST1292 serotype-6C isolates. ST376 is the genetic identifier of the well-characterized resistant 6A clone North Carolina 6A -23 (see the Pneumococcal Molecular Epidemiology Network clone collection at http://www.sph .emory.edu/PMEN/pmen_clone_collection.html).
Additionally, PNS isolates were observed within serotypes 1, 23B, 16F, 17F, 31, 15B/C, 22F, and 37F (Table 2) . Pneumococcal isolates of these serotypes are normally penicillin susceptible. All 5 serotype-23B isolates had 5-7-allele profiles that were consistent with ST1373. ST1373 was originally found within a serotype-19F IPD isolate recovered during 2001 [11] . ST1373 is a SLV of ST172 and is commonly found within PNS isolates of serotype 23A and other serotypes [11, 12] ; however, this and related sequence types have not been previously documented within serotype 23B. Three divergent profiles were found among 4 16F isolates, all 3 of which were consistent with sequence types associated with previously characterized 16F isolates. The 3 type-22F PNS isolates were projected to have genotypes either identical or highly similar to ST433, the major sequence type for invasive type-22F isolates recovered in the United States before and after PCV7 introduction [11, 12] . The 3 type-15B/C PNS isolates displayed 2 highly related genotypes that were distinct from ST199, the major genotype associated with this serotype among invasive isolates in the United States [11, 12] . Single PNS isolates were recovered among serotypes 1, 37, 31, and 17F. With the exception of the sequence type found from the type-37 isolate, their projected sequence types have been previously associated with penicillin-sensitive invasive isolates of these same serotypes in the United States prior to PCV7 implementation. The serotype-37 isolate was judged to be a pneumococcal strain on the basis of optochin sensitivity, bile solubility, and serotype; however, the 4 sequenced alleles shared only 95.5%-97.9% of their identities with the closest matches within the pneumococcal database (data not shown).
The gdh sequence of this type-37 isolate was identical to ac- cession AY525806, reported from a bacterial strain that was optochin susceptible and tested positive (via PCR) for the pneumococcal targets lytA and ply, but this strain was not bile soluble [15] . On the basis of MLST results primarily indicative of genotypes that were associated in the pre-PCV7 period with the serotypes studied here, the majority of the recent increases in IPD and increased nonsusceptibility to penicillin associated with these serotypes cannot be attributed to recent capsular switching events. It should be noted, however, that there is MLST-based evidence of multiple serotype 6A to 6C capsular switching events, which have contributed to a diverse serotype-6C genetic structure. In addition, the major ST338 type-23A penicillin-nonsusceptible clone apparently arose in the pre-PCV7 era through a capsular switch (or structural alteration) involving the putatively preexisting ST338 Colombia 23F -26 strain [13] . A factor that has potentially led to the modestly increased disease rates for these strains in the post-PCV7 era [4] is that decreased carriage of PCV7-serotype strains has provided a biologic niche for preexisting nonvaccine-serotype strains, especially those that are nonsusceptible to antibiotics. These serotypes are not included in the soon-to-be-introduced 13-valent conjugate vaccine, which makes their continued monitoring important.
